Last reviewed · How we verify

NCT03922828

Lung Nodule Prospective Database

Completed Last updated 1 October 2021
What this trial tests

trial testing CT scans in Lung Neoplasms in 20 participants. Completed in 1 January 2021.

Timeline
1 May 2018
Primary endpoint
1 January 2021
1 January 2021

Quick facts

Lead sponsorSingapore General Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date1 May 2018
Primary completion1 January 2021
Estimated completion1 January 2021
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

Singapore General Hospital

Who can join

Adults 21 to 120, any sex, with Lung Neoplasms or Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Lung cancer is one of the most common cancers in the Singapore population, being the 2nd most commonly diagnosed cancer amongst males and 3rd most commonly diagnosed cancer amongst females. Pulmonologists, oncologists and thoracic surgeons are often consulted for the evaluation of imaging-identified pulmonary nodules. These may have been identified either incidentally or through screening. The majority of these are indeterminate and definitive investigation with biopsy or resection is invasive and not without risk. Hence, current consensus guidelines adopt a largely expectant strategy in the management of these indeterminate pulmonary nodules. There is substantial evidence that lung cancer in Asians may be unique with multiple driver mutations, lower age of presentation and may be independent of tobacco exposure. In addition, there are guidelines that recommend that the management of lung nodules in Asia should account for these differences. However, the evidence for alternative recommendations is lacking. The aim of the study will be to identify radiological and clinical predictors that can improve the diagnosis of lung nodules. These predictors may help build a model for lung nodule evaluation and surveillance. Prospective database of subjects meeting all of the following inclusion criteria to participate in this study. 1. Evidence of lung nodule on chest radiograph or Computed Tomography regardless of underlying aetiology 2. Age ³ 21 years old 3. Ability to provide informed consent This study will collect existing or prospective data that is part of standard clinical care from the electronic medical record of patients (ambulatory and inpatient from May 2018-2023.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of CT scans

Trials testing the same drug.

Other recruiting trials for Lung Neoplasms

Currently open trials in the same condition.

Other Singapore General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03922828.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing